These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27266227)

  • 1. Positron Emission Mammography for Breast Cancer in Rajavithi Hospital.
    Boonyaleepan A
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S130-5. PubMed ID: 27266227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE
    AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
    Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA;
    Breast J; 2006; 12(4):309-23. PubMed ID: 16848840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection?
    Müller FH; Farahati J; Müller AG; Gillman E; Hentschel M
    Nuklearmedizin; 2016; 55(1):15-20. PubMed ID: 26627876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.
    Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW
    Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
    Bitencourt AG; Lima EN; Macedo BR; Conrado JL; Marques EF; Chojniak R
    Eur Radiol; 2017 May; 27(5):1893-1900. PubMed ID: 27585658
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Watanabe G; Itoh M; Duan X; Watabe H; Mori N; Tada H; Suzuki A; Miyashita M; Ohuchi N; Ishida T
    Eur Radiol; 2018 May; 28(5):1929-1937. PubMed ID: 29218614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission mammography: diagnostic imaging and biopsy on the same day.
    Argus A; Mahoney MC
    AJR Am J Roentgenol; 2014 Jan; 202(1):216-22. PubMed ID: 24370147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Ozonoff A; Miller JP; Kalinyak JE
    Radiology; 2011 Jan; 258(1):59-72. PubMed ID: 21076089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
    Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH
    J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Detection Using a Low-Dose Positron Emission Digital Mammography System.
    Freitas V; Li X; Scaranelo A; Au F; Kulkarni S; Ghai S; Taeb S; Bubon O; Baldassi B; Komarov B; Parker S; Macsemchuk CA; Waterston M; Olsen KO; Reznik A
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230020. PubMed ID: 38334470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer.
    Tafra L; Cheng Z; Uddo J; Lobrano MB; Stein W; Berg WA; Levine E; Weinberg IN; Narayanan D; Ross E; Beylin D; Yarnall S; Keen R; Sawyer K; Van Geffen J; Freimanis RL; Staab E; Adler LP; Lovelace J; Shen P; Stewart J; Dolinsky S
    Am J Surg; 2005 Oct; 190(4):628-32. PubMed ID: 16164937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging.
    Schilling K; Narayanan D; Kalinyak JE; The J; Velasquez MV; Kahn S; Saady M; Mahal R; Chrystal L
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):23-36. PubMed ID: 20871992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary report of breast cancer screening by positron emission mammography.
    Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
    Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
    Wang CL; MacDonald LR; Rogers JV; Aravkin A; Haseley DR; Beatty JD
    AJR Am J Roentgenol; 2011 Aug; 197(2):W247-55. PubMed ID: 21785049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
    Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
    Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron Emission Mammography Image Interpretation for Reduced Image Count Levels.
    MacDonald LR; Hippe DS; Bender LC; Cotter EW; Voria PR; Hallam PS; Wang CL; Haseley DR; Kelly MM; Parikh JR; Beatty JD; Rogers JV
    J Nucl Med; 2016 Mar; 57(3):348-54. PubMed ID: 26635337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission mammography: initial clinical results.
    Levine EA; Freimanis RI; Perrier ND; Morton K; Lesko NM; Bergman S; Geisinger KR; Williams RC; Sharpe C; Zavarzin V; Weinberg IN; Stepanov PY; Beylin D; Lauckner K; Doss M; Lovelace J; Adler LP
    Ann Surg Oncol; 2003; 10(1):86-91. PubMed ID: 12513966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of positron emission mammography: feature analysis and rates of malignancy.
    Narayanan D; Madsen KS; Kalinyak JE; Berg WA
    AJR Am J Roentgenol; 2011 Apr; 196(4):956-70. PubMed ID: 21427350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging sensitivity of dedicated positron emission mammography in relation to tumor size.
    Eo JS; Chun IK; Paeng JC; Kang KW; Lee SM; Han W; Noh DY; Chung JK; Lee DS
    Breast; 2012 Feb; 21(1):66-71. PubMed ID: 21871801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.